HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the GRUVE Anterior Cervical Plate System.
The innovation of the GRUVE Anterior Cervical Plate allows for extreme bone screw angulation, large graft windows, in addition to a tactile and visual confirmation of the locking mechanism during final screw placement.
GRUVE is the latest addition to the company’s cervical platform and marks the eighth cervical plating option for spine surgeons across the globe. “Our comprehensive cervical portfolio reinforces Life Spine’s commitment to providing single-source, cohesive procedural solutions to our customers,” said Joe Loy, Executive Vice President of Sales at Life Spine. The current anterior cervical product offering already consists of five static systems (NEO®, NEO-SL, NEO-UL, IRIS® and PRO-LINK®) and two internally dynamizing systems (KINETIC® and KINETIC-SL).
GRUVE is scheduled for limited release at the beginning of 2016 with full product release expected in the second quarter of 2016.
About Life Spine
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit http://www.lifespine.com.
